How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,699 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Immediate postpartum intrauterine device and implant program outcomes: A prospective analysis. (PubMed)

Immediate postpartum intrauterine device and implant program outcomes: A prospective analysis. In-hospital placement of intrauterine devices and contraceptive implants following vaginal and cesarean delivery is increasingly popular and responds to maternal motivation for highly effective postpartum contraception. Immediate postpartum intrauterine device insertion is associated with higher expulsion than interval placement, but emerging evidence suggests that the levonorgestrel intrauterine (...) device may have a higher expulsion rate than the copper intrauterine device.This study evaluated in-hospital provision, expulsion, and 6-month continuation of immediate postpartum copper T380 intrauterine devices, levonorgestrel intrauterine devices, and contraceptive implants.We offered enrollment in this prospective observational trial to women presenting to the University of Utah labor and delivery unit from October 2013 through February 2016 who requested an intrauterine device or implant

2017 American Journal of Obstetrics and Gynecology

142. Continuation of copper and levonorgestrel intrauterine devices: A retrospective cohort study. (PubMed)

Continuation of copper and levonorgestrel intrauterine devices: A retrospective cohort study. Studies conflict on whether the duration of use of the copper intrauterine device is longer than that of the levonorgestrel intrauterine device, and whether women who continue using intrauterine devices differ from those who discontinue.We sought to assess continuation rates and performance of levonorgestrel intrauterine devices compared with copper intrauterine devices over a 5-year period.We (...) performed a retrospective cohort study of 1164 individuals who underwent intrauterine device placement at an urban academic medical center. The analysis focused on a comparison of continuation rates between those using levonorgestrel intrauterine device and copper intrauterine device, factors associated with discontinuation, and intrauterine device performance. We assessed the differences in continuation at discrete time points, pregnancy, and expulsion rates using χ2 tests and calculated hazard ratios

Full Text available with Trip Pro

2017 American Journal of Obstetrics and Gynecology

143. Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration. (PubMed)

Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration. The subdermal contraceptive implant and the 52-mg levonorgestrel intrauterine device are currently Food and Drug Administration approved for 3 and 5 years of use, respectively. Limited available data suggested both of these methods are effective beyond that time. Demonstration of prolonged effectiveness will improve the cost-effectiveness of the device, and potentially (...) patient continuation and satisfaction.We sought to evaluate the effectiveness of the contraceptive implant and the 52-mg hormonal intrauterine device in women using the method for 2 years beyond the current Food and Drug Administration-approved duration.We initiated this ongoing prospective cohort study in January 2012. We are enrolling women using the contraceptive implant or 52-mg levonorgestrel intrauterine device for a minimum of 3 and 5 years, respectively (started intrauterine device in ≥2007

Full Text available with Trip Pro

2017 American Journal of Obstetrics and Gynecology

144. Intrauterine Device Insertion: a Step for High Satisfaction:

Intrauterine Device Insertion: a Step for High Satisfaction: Intrauterine Device Insertion: a Step for High Satisfaction: - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Intrauterine Device Insertion (...) Information provided by (Responsible Party): Mohammed Khairy Ali, Assiut University Study Details Study Description Go to Brief Summary: The intrauterine device is a safe, reliable and long-acting reversible contraceptive method. Instrumentation of lower genital mucosa during intrauterine device application provokes pain because it is highly sensitive to touch. Fear of pain associated with intrauterine device insertion is considered a barrier to use this contraception method. The classic insertion

2017 Clinical Trials

145. Intrauterine device embedded in omentum of postpartum patient with a markedly retroverted uterus: a case report (PubMed)

Intrauterine device embedded in omentum of postpartum patient with a markedly retroverted uterus: a case report The intrauterine device is a popular form of long-acting reversible contraception. Although generally safe, one of the most serious complications of intrauterine device use is uterine perforation. Risk factors for perforation include position of the uterus, force exerted during intrauterine device insertion, postpartum period, and breastfeeding. This case is important and needs (...) to be reported because it highlights the need to assess risk factors for uterine perforation. It adds to the medical literature because it examines the relationship between position of the uterus and the location of uterine perforation. This case report is unusual in that it describes the mechanism and specific location of uterine perforation in relation to the position of the uterus.We present a case of an intrauterine device found in the omentum of a 30-year-old white postpartum woman with a significantly

Full Text available with Trip Pro

2017 Journal of medical case reports

146. Pelvic abscess complicating sigmoid colon perforation by migrating intrauterine device: A case report and review of the literature (PubMed)

Pelvic abscess complicating sigmoid colon perforation by migrating intrauterine device: A case report and review of the literature Intrauterine devices (IUDs) are commonly used as a contraceptive method. However, they may cause rare but potentially serious complications such as migration through the uterine wall and gastrointestinal perforation.We report a case of a 26-year woman, carrying an IUD for 2 years, who presented to the emergency with pelvic pain with breakthrough bleeding. Abdominal (...) imaging revealed the presence of two devices the first of which was located in the uterine cavity and the other in the wall of the sigmoid colon associated with a 5-centimeter pelvic collection. Intraoperatively, the IUD was found to be embedded in the wall of the sigmoid colon which was removed by wedge resection of the involved segment followed by a closure of the puncture with drainage.The Intrauterine Device (IUD) is an effective method of contraception, relatively well tolerated, reversible

Full Text available with Trip Pro

2017 International journal of surgery case reports

147. Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury (PubMed)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury Oral contraceptives have long been associated with liver injury. However, very little attention is paid to the metabolic side effects of hormone-releasing intrauterine devices (IUDs). These devices are generally considered safe and commonly used. We report for the first time acute liver injury associated with a levonorgestrel-releasing IUD. Our patient did not have any comorbidities that could have caused or exacerbated (...) liver injury. A detailed workup and liver biopsy remained negative for any other potential cause of liver injury. The patient's symptoms resolved with removal of the device. She remained symptom free on subsequent outpatient follow-ups.

Full Text available with Trip Pro

2017 Case reports in gastroenterology

148. Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices. (PubMed)

Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices. To determine if there are any differences in the patient populations that choose subdermal implants versus intrauterine devices (IUDs) for contraceptive purposes.Retrospective chart review. Electronic medical records of women who presented to the University of Texas Medical Branch in Galveston's Regional Maternal Child Health Program Clinics in southeast Texas from March 2011 to March 2013 and received a subdermal

2017 Journal of Reproductive Medicine

149. Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users

Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier

2017 Clinical Trials

150. Use Sonography in Patients With Intrauterine Device Presenting With Bleeding

Use Sonography in Patients With Intrauterine Device Presenting With Bleeding Use Sonography in Patients With Intrauterine Device Presenting With Bleeding - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Use (...) Sonography in Patients With Intrauterine Device Presenting With Bleeding The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03140800 Recruitment Status : Not yet recruiting First Posted : May 4, 2017 Last Update Posted : May 4

2017 Clinical Trials

151. Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion

Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Early (...) Versus Late Interval Postpartum Copper Intrauterine Device Insertion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03106805 Recruitment Status : Recruiting First Posted : April 10, 2017 Last Update Posted : August 16

2017 Clinical Trials

152. Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery

Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03166111

2017 Clinical Trials

153. Intra-cesarean insertion and fixation of frameless intrauterine devices (PubMed)

Intra-cesarean insertion and fixation of frameless intrauterine devices Various contraceptive methods are available to postpartum women including hormonal and nonhormonal barriers, as well as injectable forms. Of all the available birth control methods, intrauterine devices (IUD) are felt by many to be the near-ideal form of contraception, and are recommended by advocacy groups, physicians, and gynecological organizations worldwide. Immediate postpartum IUD insertion deserves greater attention

Full Text available with Trip Pro

2017 Turkish Journal of Obstetrics and Gynecology

154. Abdominal and pelvic actinomycosis due to longstanding intrauterine device: a slow and devastating infection (PubMed)

Abdominal and pelvic actinomycosis due to longstanding intrauterine device: a slow and devastating infection Actinomycosis is a chronic or subacute bacterial infection characterized by large abscess formation, caused mainly by the gram-positive non-acid-fast, anaerobic, or microaerophilic/capnophilic, obligate parasites bacteria from the Actinomyces genus. Although pelvic inflammatory disease is an entity associated with the longstanding use of intrauterine devices (IUDs), actinomycosis

Full Text available with Trip Pro

2017 Autopsy & Case Reports

155. An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device (PubMed)

An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device Because of a previous association of pseudotumor cerebri (PTC) with levonorgestrel, we wished to evaluate the use of levonorgestrel-eluting intrauterine devices ("levonorgestrel intrauterine systems", LNG-IUS) in our University of Utah and Rigshospitalet PTC patients. In our retrospective series, PTC prevalence was approximately 0.18% and 0.15% in the LNG-IUS population versus 0.02% and 0.04

Full Text available with Trip Pro

2017 Neuro-Ophthalmology

156. Women’s willingness and ability to feel the strings of their intrauterine device (PubMed)

Women’s willingness and ability to feel the strings of their intrauterine device To determine how many intrauterine device (IUD) users are willing and able to palpate their IUD strings.A cross-sectional survey was conducted among IUD users presenting for their 6-week follow-up visit after insertion at the University of Hawaii, USA, between January 2011 and January 2012. Participants were asked whether they had previously felt the strings and whether they were willing to do so during the visit

Full Text available with Trip Pro

2017 International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

157. Intravesical Migration of an Intrauterine Contraceptive Device with Secondary Calculus Formation (PubMed)

Intravesical Migration of an Intrauterine Contraceptive Device with Secondary Calculus Formation Intrauterine contraceptive devices (IUCDs) are a common form of reversible contraception owing to fewer systemic side effects and low cost, especially in a developing country like India. However, IUCDs are not without complications. Migration of a device into adjacent organs is the most morbid of all the documented complications. A patient who presents with a history that suggests loss (...) or disappearance of an IUCD thread associated with urinary symptoms should raise suspicions that a device may have migrated into the bladder. Physicians should also be aware of possible secondary vesical calculus formation. Further radiological investigations and appropriate management are warranted. We present a case report describing the migration of an IUCD into the bladder with secondary calculus formation.

Full Text available with Trip Pro

2017 Korean journal of family medicine

158. Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion (PubMed)

Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion Long-acting reversible contraceptives such as intrauterine devices (IUDs) are highly effective in preventing pregnancy, cost effective, and increasing in popularity. It is unclear whether changes in IUD use are associated with changes in rates of irreversible tubal sterilization. In this analysis, we evaluate changes in rates of tubal sterilization, insertion of copper or levonorgestrel

Full Text available with Trip Pro

2017 Reproductive health

159. Chronic Systemic Toxicity Study of Copper Intrauterine Devices in Female Wistar Rats (PubMed)

Chronic Systemic Toxicity Study of Copper Intrauterine Devices in Female Wistar Rats BACKGROUND The aim of this study was to evaluate the chronic systemic and local toxicity of a copper intrauterine device in a rat model. MATERIAL AND METHODS Cu-IUD fragments were inserted into the uterine horns of female Wistar rats for 26 weeks (equivalent 15.42-17.33 years in humans). We tested copper at 20, 40, and 60 times the clinical dosages to study copper toxicity under severe conditions. Classic

Full Text available with Trip Pro

2017 Medical science monitor : international medical journal of experimental and clinical research

160. Correction to: Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion (PubMed)

Correction to: Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion 28985748 2018 11 13 1742-4755 14 1 2017 10 06 Reproductive health Reprod Health Correction to: Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion. 126 10.1186/s12978-017-0386-2 Howard Brandon B Teva Global Medical Affairs, 41 Moores Road, Frazer, PA, 19355, USA. Brandihoward@gmail.com. Grubb ElizaBeth E Teva Global

Full Text available with Trip Pro

2017 Reproductive health

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>